Catheter Precision Inc (VTAK)
0.5936
-0.02
(-2.69%)
USD |
NYAM |
May 17, 16:00
0.5936
0.00 (0.00%)
After-Hours: 20:00
Catheter Precision Research and Development Expense (TTM): 0.272M for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.272M |
| December 31, 2023 | 0.475M |
| September 30, 2023 | 0.64M |
| June 30, 2023 | 1.255M |
| March 31, 2023 | 3.517M |
| December 31, 2022 | 6.392M |
| September 30, 2022 | 9.97M |
| June 30, 2022 | 12.18M |
| March 31, 2022 | 12.62M |
| December 31, 2021 | 12.25M |
| September 30, 2021 | 11.94M |
| June 30, 2021 | 11.31M |
| March 31, 2021 | 10.44M |
| Date | Value |
|---|---|
| December 31, 2020 | 8.981M |
| September 30, 2020 | 6.398M |
| June 30, 2020 | 5.268M |
| March 31, 2020 | 4.294M |
| December 31, 2019 | 4.53M |
| September 30, 2019 | 4.936M |
| June 30, 2019 | 3.978M |
| March 31, 2019 | 4.021M |
| December 31, 2018 | 2.776M |
| September 30, 2018 | 1.891M |
| June 30, 2018 | 2.08M |
| March 31, 2018 | 4.425M |
| December 31, 2017 | 4.518M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
0.272M
Minimum
Mar 2024
12.62M
Maximum
Mar 2022
6.583M
Average
5.83M
Median
Research and Development Expense (TTM) Benchmarks
| Perspective Therapeutics Inc | 24.91M |
| Retractable Technologies Inc | 0.5812M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 1.689M |
| Asensus Surgical Inc | 34.98M |